pharmaceutical investing Ultragenyx, Kyowa Kirin Announce FDA Acceptance for Supplemental Biologics License
Quebec Innovative Materials Corp. Announces U.S. Affiliate Orvian Receives Minnesota DNR Registration for Exploratory Boring